Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Revenue

Advent Pharma had revenue of 119.24M BDT in the quarter ending September 30, 2025, with 16.85% growth. This brings the company's revenue in the last twelve months to 517.69M, down -0.84% year-over-year. In the fiscal year ending June 30, 2025, Advent Pharma had annual revenue of 500.49M, down -12.45%.

• Revenue (ttm): 517.69M
• Revenue Growth: -0.84%
• P/S Ratio: 2.37
• Revenue / Employee: 1.63M
• Employees: 317
• Market Cap: 1.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	500.49M	-71.18M	-12.45%
Jun 30, 2024	571.67M	13.62M	2.44%
Jun 30, 2023	558.05M	27.58M	5.20%
Jun 30, 2022	530.47M	26.87M	5.34%
Jun 30, 2021	503.60M	-30.43M	-5.70%